Market Research Report
World Vaccines Industry and Market 2015-2025
|Published by||Visiongain Ltd||Product code||206669|
|Published||Content info||169 Pages
Delivery time: 1-2 business days
See what the future holds for vaccines. Visiongain's updated report lets you assess forecasted sales at overall world market, submarket, product and national level to 2025.
Make sure you understand trends, R&D, opportunities and prospects there, in human medicine. That way you can help your research, analysis and decisions. For those technologies, discover in our study what's likely to happen. And find what gains are possible.
Vaccines still hold great technological, medical and commercial potential. See why. So please read on to explore that industry and hear what its future market could be worth.
Besides revenue forecasting to 2025, our new work gives you historical data, recent results, growth rates and market shares. There you find business outlooks and developments (R&D).
You also get 50 tables, 49 charts and two interviews, with other opinion. That study includes our discussions with GSK and BiondVax Pharmaceuticals.
Leaders hold knowledge. So hear what's happening for development, production and sales of those preventative medicines. There, from 2015, you see where needs and money exist.
And avoid struggles to gain business information. Instead use our predictions for vaccination to expand your business and help your influence. That way, benefit your authority and stay ahead.
Discover how you and your organisation can gain. The following sections reveal what you get in that new investigation.
What's that industry's potential? What're the secrets of its progress? Discover in our report overall world revenue to 2025. Also find individual forecasts for main submarkets at world level:
How will sales rise? See, then, which product classes can generate most revenue. There you assess prospects for commercial expansion. Discover now the money-earning potential.
Explore the market for vaccinations by brand too.
How will leading brands perform to 2025 at world level? Our work shows you 10 individual revenue forecasts to 2025 for top products:
And also for these agents:
There you assess potentials, seeing activities, results and outlooks. You discover what's happening, understanding trends, competition and sales prospects. Assess the future, then, including prospects for newer agents.
Also see how newer agents, especially those in development and awaiting launch, can perform. For these 11 medicines, see revenues to 2025:
And get forecasts for these treatments:
There you assess the future of that industry's developments, finding sales gains possible.
Our study also divides its overarching world forecast into geographical regions.
Progress worldwide in vaccines and healthcare will expand vaccination. You hear about the best revenue prospects for those preventative medicines, getting feel for national prospects.
Our analyses show you individual revenue forecasts to 2025 for 11 national markets:
There you assess developed and developing countries for revenues and potential sales growth. Our work explains. See effects of existing and future prophylactic medicines.
Our study discusses R&D for immune system modifiers, finding possibilities for technological and commercial advances.
In particular, our report discusses these medical technologies:
Developments in those immunological treatments hold strength, variety and promise. See what's possible there for large pharmaceutical companies and biopharma specialists.
Our study explains progress in human prophylaxis, discussing issues to help your work.
The report explains forces affecting that industry and market from 2015, including these issues:
There you explore political, economic, social and technological questions, investigating outlooks for business. Examine forces stimulating and restraining that industry and market.
You discover what their present and future hold.
What happens next? Our report predicts the overall world market for vaccines will reach $56.38bn worldwide in 2019, with strong further expansion to 2025.
Find how high its revenues can go. Discover in our work what's possible for prophylactic medicine and see which companies hold greatest potential.
In particular, you explore these organisations:
From 2015 to 2025 vaccines will benefit patients, payers and companies. Our analysis predicts technological and commercial advances there. Stay ahead by using that work.
In particular, our new investigation gives you these advantages for your research, analyses and decisions:
World Vaccines Industry and Market 2015-2025 provides independent research and analysis. There you get competitive intelligence found only in our work, finding where the money lies. Explore progress and possibilities.
With that report, by in-house UK-based analysts, you're less likely to miss knowledge and opportunity. Also find there how you could save time and gain more recognition for insight.
Our investigation is for everyone analysing preventative medicines and related biotechnology. There you discover predictions and discussions for vaccines. Avoid missing out. Instead please get that new report here now.
Visiongain is a trading partner with the US Federal Government.